Brieflands

History

The company was first founded by Seyyed M. Miri and Seyed-M Alavian as an editorial group in a Medical Institute in 2007 to publish its medical journal. After three years of experience, the number of journals increased to 5 journals, and the company launched its first form of business as a VOF (collaboration) professional STM company in Heerlen, the Netherlands, which was called "Kowsarmedical Publishing." Respecting the publishing services (from submission to publishing), especially an in-house "Journal Management System," our journals increased to more than 60 STM journals between 2010 and 2019. Since 2022, "Brieflands" is the new brand name that acts as a "Science, Technical, Medical Publisher" that publishes more than 50 journals with the services provided by 97 expert employees in three different branches.


Business Profile

  • Brieflands is a Registered Trademark with record number 1454012.
  • Brieflands has been registered as a General partnership (Vennootschap onder firma) company in the Chamber of Commerce (Kamer van Koophandel) of the Netherlands since 2010.
  • Nedmedica is our related company which is specialized in Author Services. 
  • Our former branding name was Kowsarmedical Publishing (2010-2021).
 

Recent Submissions

Item
HIV-Related Stigma Can Be Reduced Within 10 Years: Findings from Two Stigma Index Studies in Iran
(Brieflands, 2024-12-31) SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Shayesteh Jahanfar
This article does not have an abstract.
Item
Quetiapine and Hyper Sexuality
(Brieflands, 2025-03-31) Seyede Maryam Naghibi; Seyed Hamzeh Hosseini; Mahla Asheghhosseini
Context: Sexual dysfunction is identified as a routine side effect following antipsychotic consumption; however, different medications present significant differences. Objectives: This study aimed to report a schizoaffective bipolar-type case of hypersexuality following quetiapine therapy and to systematically review the available instances of the association between hypersexuality and quetiapine. Methods: Cases of hypersexuality after taking quetiapine were searched without time restriction until November 16, 2022, under the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline. The terms "Compulsive sexual behavior", "Hypersexuality", "Sexual addiction", "Libido", "Compulsive sexual disorder", "Sexual compulsivity", "Hypersexual", and "Quetiapine" were searched in PubMed, Scopus, and ISI Web of Knowledge databases. All case reports and case series were included. Extracted data include authors, year, age, sex, underlying diseases, medication types, medication dose, the effect of medication, and treatment trends. Results: Alongside the present case in this study, six studies, including seven cases, reported the relationship between hypersexuality and quetiapine. Four hypersexual cases improved by adding quetiapine to their treatment panel. On the other hand, similar to the present case in this study, three cases indicated hypersexuality after quetiapine consumption; one of them was treated after 4 - 6 weeks without dosage change, and others achieved improvement following dosage reduction. Conclusions: Although some evidence reported improvement in hypersexuality following quetiapine consumption, an increased sexual drive has also been observed after taking quetiapine. These findings may present the dual role of quetiapine in sexual functioning, suggesting more attention to underlying disease, dosage, and medication interactions.
Item
Phenomenology of Family Support in Gender Dysphoria
(Brieflands, 2025-02-13) Fahime Akhlaghi Buzani; Zanireh Salimi; Reza Bidaki; Zohreh Mahdianpour
Background: The present study aimed to investigate the phenomenology of family support in the experiences of transsexual individuals and to address gaps in understanding minority experiences in Iran. Methods: This qualitative study involved a statistical population of 15 individuals with gender dysphoria, nominated by the Tehran Institute of Psychiatry. Purposive sampling was employed to select participants of varying ages to achieve data saturation. Interviews were conducted, and the text was analyzed using Colaizzi's phenomenological analysis method. The research questions focused on significant life events and turning points, particularly the stage of gender reassignment surgery. Results: The categories extracted include: "Conditions that influence one's experience of being transsexual", "transsexuals influence on aspects of one's life", "one's experiences of transsexual phenomena", "one's reaction to perceiving one's transsexual", "a person's family reaction when they found out their child is transsexual", "a person's family's reaction to his or her gender change surgery", "family behavior and reaction after surgery", "a person's reaction to family behavior after surgery", and "one's action on surgery and the impact of that action on his or her family's attitudes". Conclusions: These extracted categories provide a framework to evaluate the future turning points in the lives of transsexual individuals, specifically focusing on gender reassignment surgery.
Item
Autologous Platelet Rich Fibrin Versus Steroid in Ultrasound-Guided Sacroiliac Joint Injection for Joint Dysfunction: Randomized Comparative Study
(Brieflands, 2025-02-28) Omar Sayed Fargaly; Mohamed Ahmed Hamed; Maged Labib Boules; Mohammed Awad Alsaied; Mohammed Magdy Basiony; Mohammad Omar Mostafa; Amr Hamdy Mahmoud; Mohamed Ahmed Shawky
Background: Sacroiliac joint (SIJ) discomfort is frequently treated with steroids, although the relief is often temporary. The use of platelet-rich fibrin (PRF) may aid in tissue healing and prolong pain relief. Objectives: This study aims to compare the analgesic effects of a single autologous PRF injection with the commonly used steroid in ultrasound-guided intra-articular SIJ injections. Methods: This randomized clinical trial was conducted in the Department of Anesthesiology and Pain Management at Fayoum University Hospitals. The study included 94 adult patients with SIJ dysfunction confirmed by positive diagnostic tests. All patients were randomly assigned into two equal groups to receive either an ultrasound-guided PRF injection (group P, n = 47) or a steroid injection (group S, n = 47). Results: The Visual Analog Scale (VAS) score immediately after injection in group P was 7.51 ± 0.78 (mean ± SD), while in sroup S, it was 5.91 ± 0.54, with a highly significant difference between the two groups (P < 0.001). At six months, the VAS score was 3.51 ± 0.78 in group P compared to 4.68 ± 0.63 in group S, again showing a highly significant difference (P < 0.001). There was no significant difference in the Oswestry Disability Index (ODI) between the groups at one and six months. Conclusions: Intra-articular PRF injection is an effective therapy option for SIJ-related low back pain, offering prolonged pain relief compared to steroid injections.
Item
Seroprevalence of Hepatitis D Virus in Northern Cyprus
(Brieflands, 2025-12-31) Emrah Güler; Luma Husni Ahmad Alzubi; Meryem Güvenir; Ulas Hurdoganoglu; Kaya Suer; Esref Celik
Background: Infection caused by the hepatitis delta virus (HDV), a defective virus, is among the important viral infections. This virus can only cause infection in the presence of the hepatitis B virus (HBV). Determining the prevalence of HDV in the general population, including risk groups, and estimating the relative contribution of HDV to liver disease development is critical to guide clinical care and strategies. Objectives: The aim of this study was to determine the seroprevalence of HDV in HBsAg (hepatitis B surface antigen)-positive patients diagnosed in a university hospital in Northern Cyprus. Methods: Four hundred serum samples with only HBsAg positivity from patients admitted to our hospital between 2016 and 2022 were analyzed in our study. Samples were removed from -80°C retrospectively, and HDV-Ag and HDV-Ab tests were performed by the manual enzyme-linked immunosorbent assay (ELISA) method following the manufacturer's recommendations. Hepatitis delta virus RNA levels in HDV-Ag and/or HDV-Ab positive serum samples were quantitated by the in-house real-time polymerase chain reaction (RT-PCR) method. Results: The HDV-Ab positivity rate was determined to be 1.3% (5/400). All patients were negative for HDV-Ag, and HDV RNA was not detected in any of the HDV-Ab positive patients. Conclusions: Based on the data obtained from our study, it was concluded that HDV seropositivity in HBsAg-positive patients is low in our country.